1. Accuretic batch recalled in UK due to nitrosamine

   Unknown 09 April 2022 Pages: 1 - 1

2. Adverse effects of oxybutynin in children

   Unknown 09 April 2022 Pages: 2 - 2

3. Drug safety update: metformin safe during pregnancy

   Clinical study 09 April 2022 Pages: 3 - 3

4. Iodine-containing contrast media may affect thyroid function in babies

   Unknown 09 April 2022 Pages: 4 - 4

5. Revision of Comirnaty precautions in Japan

   Unknown 09 April 2022 Pages: 5 - 5

6. Voluntary recall of IDArubicin Hydrochloride Injection USP 5mg/5mL in the USA

   Unknown 09 April 2022 Pages: 6 - 6

7. ADR-related hospitalisation in patients with dementia

   Unknown 09 April 2022 Pages: 7 - 7

8. Antidopaminergic antiemetics increase risk of stroke

   Unknown 09 April 2022 Pages: 8 - 8

9. Inconsistent procedures for handling new drug safety information in the Netherlands

   Unknown 09 April 2022 Pages: 9 - 9

10. No evidence of adverse neurological outcomes from COVID-19 vaccines

    Unknown 09 April 2022 Pages: 10 - 10

11. Pre-COVID-19 psychotropic medication use linked to higher rate of dementia

    Unknown 09 April 2022 Pages: 11 - 11

12. Remdesivir does not increase risk of AKI or ALI in COVID-19 patients

    Clinical study 09 April 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 09 April 2022 Pages: 13 - 13

14. β-adrenergic-receptor-antagonists/dexmedetomidine

    Case report 09 April 2022 Pages: 14 - 14

15. Aciclovir

    Case report 09 April 2022 Pages: 15 - 15

16. Ad26.cov2-s

    Case report 09 April 2022 Pages: 16 - 16

17. Adalimumab

    Case report 09 April 2022 Pages: 17 - 17

18. Adalimumab/etanercept/prednisone

    Case report 09 April 2022 Pages: 18 - 18

19. Adalimumab/methotrexate

    Case report 09 April 2022 Pages: 19 - 19

20. Adalimumab/methotrexate/secukinumab

    Case report 09 April 2022 Pages: 20 - 20

21. Adenosine

    Case report 09 April 2022 Pages: 21 - 21

22. Adenosine/amiodarone/lisdexamfetamine

    Case report 09 April 2022 Pages: 22 - 22

23. Adenosine/diltiazem/verapamil

    Case report 09 April 2022 Pages: 23 - 23

24. Adenosine/metoprolol-tartrate

    Case report 09 April 2022 Pages: 24 - 24

25. Afatinib

    Case report 09 April 2022 Pages: 25 - 25

26. Albumin human/parenteral nutrition supplements

    Case report 09 April 2022 Pages: 26 - 26

27. Alectinib

    Case report 09 April 2022 Pages: 27 - 27

28. Alectinib/ceritinib/crizotinib

    Case report 09 April 2022 Pages: 28 - 28

29. Alemtuzumab

    Case report 09 April 2022 Pages: 29 - 29

30. Alendronic-acid

    Case report 09 April 2022 Pages: 30 - 30

31. Alendronic-acid

    Case report 09 April 2022 Pages: 31 - 31

32. Alprostadil/epinephrine

    Case report 09 April 2022 Pages: 32 - 32

33. Alteplase/heparin/local-anaesthetics

    Case report 09 April 2022 Pages: 33 - 33

34. Alteplase/rivaroxaban

    Case report 09 April 2022 Pages: 34 - 34

35. Ambrisentan/riociguat

    Case report 09 April 2022 Pages: 35 - 35

36. Amiodarone

    Case report 09 April 2022 Pages: 36 - 36

37. Amiodarone

    Case report 09 April 2022 Pages: 37 - 37

38. Amiodarone/antiarrhythmic/sedative

    Case report 09 April 2022 Pages: 38 - 38

39. Amiodarone/atenolol/sotalol

    Case report 09 April 2022 Pages: 39 - 39

40. Amiodarone/atropine

    Case report 09 April 2022 Pages: 40 - 40

41. Amiodarone/digoxin/diltiazem

    Case report 09 April 2022 Pages: 41 - 41

42. Amiodarone/digoxin/infliximab

    Case report 09 April 2022 Pages: 42 - 42

43. Amiodarone/lidocaine

    Case report 09 April 2022 Pages: 43 - 43

44. Amiodarone/lidocaine

    Case report 09 April 2022 Pages: 44 - 44

45. Amiodarone/lidocaine/mexiletine

    Case report 09 April 2022 Pages: 45 - 45

46. Amiodarone/metoprolol-succinate

    Case report 09 April 2022 Pages: 46 - 46

47. Amiodarone/milrinone

    Case report 09 April 2022 Pages: 47 - 47

48. Amiodarone/propranolol

    Case report 09 April 2022 Pages: 48 - 48

49. Amiodarone/sotalol

    Case report 09 April 2022 Pages: 49 - 49

50. Amiodarone/ticagrelor

    Case report 09 April 2022 Pages: 50 - 50